Envoy Medical Files 8-K with Financial Updates
Ticker: COCHW · Form: 8-K · Filed: Jul 15, 2024 · CIK: 1840877
Sentiment: neutral
Topics: corporate-filing, financial-reporting, company-update
Related Tickers: COCH
TL;DR
Envoy Medical (COCH) filed an 8-K on 7/15, updating financials and corporate info. Former name was Anzu Special Acquisition Corp I.
AI Summary
Envoy Medical, Inc. filed an 8-K on July 15, 2024, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing indicates the company's fiscal year ends on December 31st and provides its principal business address in White Bear Lake, MN. It also notes a former company name, Anzu Special Acquisition Corp I, with a name change date of January 15, 2021.
Why It Matters
This 8-K filing provides essential updates on Envoy Medical's corporate status and financial reporting, which are crucial for investors to understand the company's current standing and regulatory compliance.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain any immediate negative news or significant financial distress.
Key Numbers
- 001-40133 — SEC File Number (Identifies the company's filing with the SEC.)
- 86-1369123 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Envoy Medical, Inc. (company) — Registrant
- July 15, 2024 (date) — Date of earliest event reported
- Anzu Special Acquisition Corp I (company) — Former company name
- January 15, 2021 (date) — Date of name change
- 4875 White Bear Parkway (location) — Principal business address
- White Bear Lake, MN (location) — City and State of principal business address
FAQ
What specific financial statements or exhibits are being filed with this 8-K?
The filing explicitly lists 'Financial Statements and Exhibits' as an item information, but the specific details of these documents are not provided in the provided text.
What was the reason for the name change from Anzu Special Acquisition Corp I to Envoy Medical, Inc.?
The filing states the date of the name change as January 15, 2021, but does not provide the specific reasons for this change.
What is the SIC code for Envoy Medical, Inc. and what does it represent?
The SIC code is 3842, which corresponds to 'ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES'.
What is the par value of Envoy Medical, Inc.'s common stock?
The filing mentions 'ClassCommonStockParValue0.0001PerShareMember', indicating a par value of $0.0001 per share for its common stock.
Does this 8-K filing relate to any specific event triggering a Regulation FD Disclosure?
The filing lists 'Regulation FD Disclosure' as an item information, suggesting a disclosure was made under these rules, but the specific event is not detailed in the provided text.
Filing Stats: 603 words · 2 min read · ~2 pages · Grade level 12.3 · Accepted 2024-07-15 08:30:28
Key Financial Figures
- $0.0001 — tered Class A Common Stock, par value $0.0001 per share COCH The Nasdaq Stock Mar
- $11.50 — A Common Stock at an exercise price of $11.50 per share COCHW The Nasdaq Stock Ma
Filing Documents
- ea0209407-8k_envoy.htm (8-K) — 30KB
- ea020940701ex99-1_envoy.htm (EX-99.1) — 52KB
- ex99-1_001.jpg (GRAPHIC) — 201KB
- ex99-1_002.jpg (GRAPHIC) — 518KB
- ex99-1_003.jpg (GRAPHIC) — 240KB
- ex99-1_004.jpg (GRAPHIC) — 348KB
- ex99-1_005.jpg (GRAPHIC) — 210KB
- ex99-1_006.jpg (GRAPHIC) — 317KB
- ex99-1_007.jpg (GRAPHIC) — 156KB
- ex99-1_008.jpg (GRAPHIC) — 199KB
- ex99-1_009.jpg (GRAPHIC) — 316KB
- ex99-1_010.jpg (GRAPHIC) — 364KB
- ex99-1_011.jpg (GRAPHIC) — 326KB
- ex99-1_012.jpg (GRAPHIC) — 295KB
- ex99-1_013.jpg (GRAPHIC) — 267KB
- ex99-1_014.jpg (GRAPHIC) — 210KB
- ex99-1_015.jpg (GRAPHIC) — 120KB
- ex99-1_016.jpg (GRAPHIC) — 174KB
- ex99-1_017.jpg (GRAPHIC) — 304KB
- ex99-1_018.jpg (GRAPHIC) — 164KB
- ex99-1_019.jpg (GRAPHIC) — 212KB
- ex99-1_020.jpg (GRAPHIC) — 147KB
- ex99-1_021.jpg (GRAPHIC) — 177KB
- ex99-1_022.jpg (GRAPHIC) — 246KB
- ex99-1_023.jpg (GRAPHIC) — 238KB
- ex99-1_024.jpg (GRAPHIC) — 249KB
- ex99-1_025.jpg (GRAPHIC) — 280KB
- ex99-1_026.jpg (GRAPHIC) — 375KB
- ex99-1_027.jpg (GRAPHIC) — 415KB
- ex99-1_028.jpg (GRAPHIC) — 246KB
- 0001213900-24-061178.txt ( ) — 10393KB
- coch-20240715.xsd (EX-101.SCH) — 4KB
- coch-20240715_def.xml (EX-101.DEF) — 26KB
- coch-20240715_lab.xml (EX-101.LAB) — 36KB
- coch-20240715_pre.xml (EX-101.PRE) — 25KB
- ea0209407-8k_envoy_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ENVOY MEDICAL, INC. July 15, 2024 By: /s/ David R. Wells David R. Wells Chief Financial Officer 2